Impact of PCSK9, WDR12, CDKN2A, and CXCL12 Polymorphisms in Jordanian Cardiovascular Patients on Warfarin Responsiveness and Sensitivity

BACKGROUND: The main objective of this study is sought to determine the impacts of PCSK9, WDR12, CDKN2A, and CXCL12 polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and stabilization phases of therapy. METHODS: This study took place...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibdah, Rasheed K, AL-Eitan, Laith N, Alrabadi, Nasr N, Almasri, Ayah Y, Alnaamneh, Adan H, Khasawneh, Rame H, Alghamdi, Mansour A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814275/
https://www.ncbi.nlm.nih.gov/pubmed/33488114
http://dx.doi.org/10.2147/IJGM.S287238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814275/
https://www.ncbi.nlm.nih.gov/pubmed/33488114
http://dx.doi.org/10.2147/IJGM.S287238

Ejemplares similares